Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Anixa Biosciences Inc (ANIX)  
$3.09 0.12 (4.04%) as of 4:30 Wed 5/1


Download
   
Exchange: OTC Bulletin Board
Security Type: Common
Shares Out: 29,950,000
Market Cap: 92.55(M)
Last Volume: 42,300 Avg Vol: 42,182
52 Week Range: $2.85 - $5.02
Level I Sector: Information Technology
Level II Sector: Computer Hardware
Level III Sector: Computer Peripherals

Member Indexes:

   

Rankings:

     
Insider 3 Months    : 9.1
Insider 6 Months    : 9.1
Insider 3/6 Months : 18.2
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Anixa Biosciences is a biotechnology company developing therapies and vaccines that are focused on unmet needs in oncology and infectious disease. Co.'s therapeutics programs include the development of a chimeric endocrine receptor T-cell therapy, a form of chimeric antigen receptor T-cell technology, initially focused on treating ovarian cancer and the discovery and development of anti-viral drug candidates for the treatment of Coronavirus disease 2019 focused on inhibiting certain protein functions of the virus. Co.'s vaccine programs include the development of a vaccine against triple negative breast cancer as well other forms of breast cancer and a vaccine against ovarian cancer.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 55,009 55,009 60,509 60,509
Total Buy Value $182,130 $182,130 $202,150 $202,150
Total People Bought 3 3 4 4
Total Buy Transactions 3 3 4 4
Total Shares Sold 0 0 11,800 11,800
Total Sell Value $0 $0 $42,126 $42,126
Total People Sold 0 0 1 1
Total Sell Transactions 0 0 1 1
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 36
  Page 2 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Titterton Lewis H Jr Director   –       •      –    2020-03-13 4 B $2.12 $12,294 D/D 5,799 924,743 2.39 35%     
   Baskies Arnold M Director   –       •      –    2020-03-12 4 B $1.84 $18,400 D/D 10,000 41,000 2.39 67%     
   Kumar Amit Chief Executive Officer   •       •      –    2020-03-12 4 B $1.82 $36,400 D/D 20,000 214,000 2.81 67%     
   Baskies Arnold M Director   –       •      –    2020-03-06 4 B $2.71 $27,100 D/D 10,000 31,000 2.39 6%     
   Baskies Arnold M Director   –       •      –    2020-01-17 4 B $3.53 $35,300 D/D 10,000 21,000 2.39 -32%     
   Titterton Lewis H Jr Director   –       •      –    2020-01-15 4 B $3.32 $16,600 D/D 5,000 918,944 2.39 -28%     
   Titterton Lewis H Jr Director   –       •      –    2020-01-14 4 B $3.22 $23,828 D/D 7,400 913,944 2.39 -38%     
   Kumar Amit Chief Executive Officer   •       •      –    2020-01-14 4 B $2.99 $59,800 D/D 20,000 194,000 2.81 -38%     
   Catelani Michael COO & CFO   •       –      –    2019-10-31 4 A $3.29 $3,000 D/D 912 3,962     -
   Titterton Lewis H Jr Director   –       •      –    2019-09-13 4 B $4.10 $61,500 D/D 15,000 906,544 2.39     -
   Kumar Amit Chief Executive Officer   •       •      –    2019-09-13 4 B $4.12 $41,200 D/D 10,000 174,000 2.81     -

  36 Records found
  1  2    
  Page 2 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed